Drug Profile
Almorexant
Alternative Names: A 573; ACT-078573; Orexin-RA-1Latest Information Update: 05 Nov 2023
Price :
$50
*
At a glance
- Originator Actelion Pharmaceuticals
- Class Acetamides; Hypnosedatives; Isoquinolines; Small molecules
- Mechanism of Action Orexin receptor type 1 antagonists; Orexin receptor type 2 antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Insomnia
Most Recent Events
- 16 Jun 2017 Actelion Pharmaceuticals was acquired by Janssen Pharmaceuticals
- 28 Jan 2011 Discontinued - Phase-II for Insomnia in USA (PO)
- 28 Jan 2011 Discontinued - Phase-III for Insomnia in Australia (PO)